Keyphrases
Myositis
94%
Idiopathic Inflammatory Myopathies
81%
Dermatomyositis
69%
Autoantibodies
46%
Systemic Sclerosis
28%
Antisynthetase Syndrome
27%
Interstitial Lung Disease
24%
Inclusion Body Myositis
23%
Myopathy
21%
Scleroderma
20%
Clinical Features
18%
Muscle Disease
17%
Muscle Biopsy
17%
Clinical Phenotype
13%
Cancer Risk
12%
Idiopathic Inflammatory Myositis
11%
Fibrosis
10%
Severe Disease
10%
Myositis Autoantibody
9%
Long-term Treatment
9%
Disease Flare
9%
Immune Response
8%
Confidence Interval
8%
Disease Course
7%
Clinical Trials
7%
Intermediary Factors
7%
Clinical Outcomes
7%
Muscle Weakness
7%
North America
7%
Muscle Involvement
7%
Clinical Presentation
7%
Risk Factors
7%
Johns Hopkins
6%
Dysphagia
6%
Systemic Lupus Erythematosus
6%
Immunosuppression
6%
Large Cohort
6%
Muscle MRI
6%
COVID-19
6%
Reductase
6%
Anti-melanoma
6%
Disease Activity
6%
Anti-PM-Scl Antibody
6%
Messenger RNA (mRNA)
6%
Juvenile Myositis
5%
Inflammation
5%
Intravenous Immunoglobulin (IVIg)
5%
Computed Tomography
5%
Rheumatic Diseases
5%
Diagnostic Tool
5%
Medicine and Dentistry
Myositis
100%
Dermatomyositis
41%
Myopathy
34%
Disease
33%
Interstitial Lung Disease
30%
Systemic Scleroderma
28%
Scleroderma
26%
Autoantibodies
25%
Antisynthetase Syndrome
20%
Malignant Neoplasm
11%
Prevalence
11%
Muscle Disease
10%
Patient Referral
10%
Cancer Screening
9%
Systematic Review
9%
Diagnosis
9%
Magnetic Resonance Imaging
9%
Computer Assisted Tomography
9%
Muscle Weakness
8%
Clinical Feature
8%
Inclusion Body Myositis
7%
Forced Vital Capacity
7%
Muscle Biopsy
6%
Fibrosis
6%
Population
5%
Oxidoreductase
5%
Immunosuppressive Treatment
5%
Autoimmune Disease
5%
Edema
5%
Rheumatology
5%
Cancer Diagnosis
5%
Immunosuppressive Drug
5%
Pharmacology, Toxicology and Pharmaceutical Science
Myositis
68%
Myopathy
46%
Dermatomyositis
34%
Autoantibodies
33%
Disease
24%
Antisynthetase Syndrome
23%
Scleroderma
21%
Interstitial Lung Disease
19%
Prevalence
16%
Malignant Neoplasm
14%
Systemic Sclerosis
12%
Cohort Study
12%
Edema
11%
Clinical Feature
9%
Inclusion Body Myositis
8%
Muscle Disease
8%
Autoimmune Disease
7%
Muscle Injury
7%
Immunosuppressive Agent
7%
Rheumatic Disease
6%
Janus Kinase Inhibitor
6%
Ribonucleoprotein
6%
Oxidoreductase
5%
Infection
5%
Myocarditis
5%
Weakness
5%
Disease Exacerbation
5%